EPANOVA Trademark

Trademark Overview

On Monday, August 30, 2010, a trademark application was filed for EPANOVA with the United States Patent and Trademark Office. The USPTO has given the EPANOVA trademark a serial number of 85118306. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by Chrysalis Pharma AG. The EPANOVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for treating the following: diseases, disorders and conditions of the gastro-intestinal tract, namely, Crohn's disease, irritable bowel syndrome and ulcerative colitis; and pharmaceutical preparations and substances for use in treating cardiovascular diseases, disorders and conditions; neurological diseases, disorders and conditions, ophthalmic diseases, disorders and conditions, feeding diseases, disorders and conditions, autoimmune diseases, disorders and conditions, inflammatory diseases, disorders and conditions, chronic pain, and dyslipidemia
epanova

General Information

Serial Number85118306
Word MarkEPANOVA
Filing DateMonday, August 30, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 5, 2020
Registration Number4425885
Registration DateTuesday, October 29, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for treating the following: diseases, disorders and conditions of the gastro-intestinal tract, namely, Crohn's disease, irritable bowel syndrome and ulcerative colitis; and pharmaceutical preparations and substances for use in treating cardiovascular diseases, disorders and conditions; neurological diseases, disorders and conditions, ophthalmic diseases, disorders and conditions, feeding diseases, disorders and conditions, autoimmune diseases, disorders and conditions, inflammatory diseases, disorders and conditions, chronic pain, and dyslipidemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateThursday, September 30, 2010
First Use In Commerce DateThursday, September 30, 2010

Trademark Owner History

Party NameChrysalis Pharma AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address6061 Sarnen 1
CH
Party NameChrysalis Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address6072 Sachseln, OW
CH
Party NameChrysalis Pharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address6072 Sachseln, OW
CH

Trademark Events

Event DateEvent Description
Friday, June 5, 2020CANCELLED SEC. 8 (6-YR)
Monday, October 29, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 7, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 7, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 29, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, September 25, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 24, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, September 23, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 17, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, September 16, 2013USE AMENDMENT FILED
Monday, September 16, 2013TEAS STATEMENT OF USE RECEIVED
Thursday, February 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 20, 2013EXTENSION 3 GRANTED
Tuesday, February 19, 2013EXTENSION 3 FILED
Tuesday, February 19, 2013TEAS EXTENSION RECEIVED
Thursday, September 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 19, 2012EXTENSION 2 GRANTED
Tuesday, September 18, 2012EXTENSION 2 FILED
Wednesday, September 19, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 18, 2012TEAS EXTENSION RECEIVED
Tuesday, March 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 16, 2012EXTENSION 1 GRANTED
Friday, March 16, 2012EXTENSION 1 FILED
Friday, March 16, 2012TEAS EXTENSION RECEIVED
Tuesday, September 20, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2011PUBLISHED FOR OPPOSITION
Friday, June 17, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 17, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 15, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 15, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 10, 2011ASSIGNED TO LIE
Friday, June 3, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 16, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 16, 2010NON-FINAL ACTION E-MAILED
Thursday, December 16, 2010NON-FINAL ACTION WRITTEN
Monday, December 13, 2010ASSIGNED TO EXAMINER
Thursday, September 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 2, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

epanova conditions disorders diseases preparations pharmaceutical treating substances cardiovascular ophthalmic neurological